ilikefinance

Revolutionizing Cardiac Care: HeartSciences Achieves Groundbreaking Milestone with AMA Approval for ECG AI Analysis

HeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association Introduction Heart Test Laboratories, Inc. d/b/a HeartSciences has recently made a significant breakthrough in the medical technology industry with the issuance of new reimbursement-related codes by the American Medical Association. This milestone is expected to accelerate the use and adoption…

Read More

Accelerus Goes Global: Flarehawk Interbody Fusion System Expands Worldwide!

Surgeons in 21 Countries Can Now Take Advantage of FlareHawk’s Innovative Features PALM BEACH GARDENS, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company, has announced the global expansion of its FlareHawk Interbody Fusion System. What is the FlareHawk Interbody Fusion System? The FlareHawk Interbody Fusion System is a groundbreaking…

Read More

Revving Up Security: Fortinet Named Official Cybersecurity Partner of BMW Ladies Championship 2022!

WONJU, South Korea, Oct. 17, 2022 (GLOBE NEWSWIRE) — Fortinet, a global leader in broad, integrated and automated cybersecurity solutions, will become the Official Cybersecurity Partner of the BMW Ladies Championship, taking place at the Oak Valley Country Club in the Republic of Korea. The partnership with the BMW Ladies Championship will represent Fortinet’s first…

Read More

Breathing Easy: The Growing Demand for Pure Indoor Air to Drive the Humidifier Market to $3.53 Billion by 2030 – Insights from Future Market Inc.

Rapid Deployment of Ultrasonic Humidifiers in Europe Cool Mist Humidifiers Gaining Traction in End-user Industries The demand for ultrasonic humidifiers is increasing rapidly in Europe, driven by their effectiveness in maintaining optimal humidity levels in various industries. These humidifiers are preferred for their cool mist output, making them ideal for a wide range of applications….

Read More

Unlocking the Potential of T-Cell Reprogramming: A Look at Lyell Immunopharma’s Latest Innovations and Pipeline at the 2022 SITC Annual Meeting

Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technology Exciting Developments in T-Cell Therapy Lyell Immunopharma, a pioneering company in the field of T-cell reprogramming, is set to unveil groundbreaking preclinical data at an upcoming conference. The data pertains to the incorporation of new T-cell reprogramming technology in LYL119, Lyell’s latest product candidate….

Read More